Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- William Blair analyst Matt Phipps initiated coverage on Climb Bio Inc (NASDAQ:CLYM) with an Outperform rating. Climb Bio shares closed at $1.94 on Wednesday. See how other analysts view this stock.
- Baird analyst Peter Arment initiated coverage on Rocket Lab Corp (NASDAQ:RKLB) with an Outperform rating and announced …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- William Blair analyst Matt Phipps initiated coverage on Climb Bio Inc (NASDAQ:CLYM) with an Outperform rating. Climb Bio shares closed at $1.94 on Wednesday. See how other analysts view this stock.
- Baird analyst Peter Arment initiated coverage on Rocket Lab Corp (NASDAQ:RKLB) with an Outperform rating and announced …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
William Blair analyst Matt Phipps initiated coverage on Climb Bio Inc (NASDAQ:CLYM) with an Outperform rating. Climb Bio shares closed at $1.94 on Wednesday. See how other analysts view this stock.
Baird analyst Peter Arment initiated coverage on Rocket Lab Corp (NASDAQ:RKLB) with an Outperform rating and announced …Full story available on Benzinga.com Read MoreCLS, CLYM, IRD, News, RKLB, Top Initiations, VERA, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, CLS, CA15101Q1081, VERA, IRD, RKLB, CLYM, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
